fiercebiotech.com
FDA has pulled a U-turn on uniQure's Huntington's disease gene therapy, giving the biotech the OK to file for accelerated approval after previously demanding data from another trial.
giving the biotech the OK to file for accelerated approval after previously demanding data from another trial
FDA U-turn clears path to gene therapy filing